Investors > As an investment

Revenio as an investment

Revenio is a global leader in ophthalmological devices and software solutions. We focus on eye care solutions; our objective is to improve the quality of clinical diagnostics with targeted product innovations and software solutions.

Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters as well as related software solutions. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

We enable efficient diagnostics of eye diseases

We use Finnish technology to improve the quality of life of people around the world. Health care megatrends, such as aging populations and a global need for cost savings, support our growth targets.

Since 2016, Revenio has been taking market share with a CAGR of approximately 27% revenue growth rate compared to the market growth rate of approximately 4-6%. When eliminating the impact of the Centervue acquisition, the growth rate has been slightly above 13%. Revenio remains committed to continued improvement of its market share on all product lines with the aim of accelerating the organic growth. The company also continues to scan the market for acquisition opportunities to expand its product portfolio within the ophthalmic diagnostics and software solutions.

Approximately half of our share capital is owned by private investors and briskly traded. We always seek to remember our owners and have a history of good dividend payment performance.

Strategy add

The cornerstones of Revenio’s strategy are (published March 16, 2021):

  • Focus fully on the eye care market

  • Improve the quality of clinical diagnostics with targeted product innovations

  • Transform clinical care pathways with eye care focused software solutions

  • Continue to develop stronger distribution and build on iCare brand awareness and client experience

  • Continue strong profitable growth

Competitive advantages add

Knowledge and people

  • Knowledge of the industry and global markets

  • Distribution channels

  • World-class quality products and processes


  • Research and development

  • Steady cash flow from sensor sales

  • Utilizing IP-protected Finnish inventions


  • Strong and respected iCare brand


  • Volume flexible production model

Financial position strong

  • Profitability and balance sheet

  • Shareholder value

Growth drivers add

Health care facing unprecedented global challenges

The global megatrends are providing us long term eye care market growth opportunities. In our view the demand for global eye care is increasing due to the aging and growing population, along with changing lifestyles. Comprehensive eye care delivery systems are becoming more important due to the increased system costs and resource shortages. Furthermore, the demand for telehealth and remote monitoring across markets is continuing to increase also due to the COVID-19 pandemic.

Key market trends on the eye care market are the following:

  • Population growth

  • Population aging

  • Inequality

  • Chronic diseases become more common

  • Infrastructures are incapable of treating the required numbers of patients

Key figures

Learn more about our financial performance


Read the analyst reports on Revenio